FOCUS ON… 13 October 2023 A second line for BioDémo With the launch of the second line of its industrial demonstrator, ARD has doubled its production capacity, giving it the ability to meet strong global demand in the field of industrial biotechnologies. Spotlight on a major advance. o meet growing global demand in molecules that replace fossil fuel-based Tbiomanufacturing, ARD invested €8 products,” adds Managing director of ARD, million in a new production line for Philippe Aubry. “With this investment, its BioDémo demonstrator. we are strengthening our position on an international market where there is strong €8 Built over a period of 18 months on demand for fermentation capacity.” the open innovation platform on the million invested biore昀椀nery of Bazancourt-Pomacle, So, the new BioDémo production and launched in June 2023, this line was line is an answer to the current lack successfully commissioned at the start of fermentation capacity worldwide, of this 昀椀nancial year, doubling ARD’s thereby supporting the growth of the bio production capacity. economy. A wide variety of customers Operating along the entire value chain, around the world from laboratory trials to industrial scale-up, the molecules ARD produces The company therefore has greater have multiple market opportunities, resources to help its customers – from with very varied applications from start-ups to major international groups – 昀椀ne chemistry to the food industry to bring to market bio-sourced molecules and healthcare. This new investment based on renewal carbon and prepare for consolidates its leading position in 35 the post-oil era. “BioDémo 2 has a new 220 the 昀椀eld of industrial biotechnologies, jobs created m³ fermenter which will enable us to carry and ARD is already preparing its next out contract manufacturing for decarbonised developments. 60